Metabolic, cognitive, and environmental factors processed in the forebrain modulate food intake by changing the potency of direct controls of meal ingestion in the brainstem. Here, we behaviorally and anatomically test the role of the hypothalamic proopiomelanocortin system in mediating some of these descending, indirect controls. MTII, a stable MC4/3R agonist injected into the 4 th ventricle near the dorsal vagal complex potently inhibited 14-h food intake by decreasing meal size but not meal frequency, and SHU9119, an antagonist increased food intake by selectively increasing meal size. Furthermore, MTII injected into the 4 th ventricle increased and SHU9119 tended to decrease heart rate and body temperature measured telemetrically in freely moving rats. Numerous α-MSH-ir axons were in close anatomical apposition to NTS neurons showing c-Fos in response to gastric distension, expressing neurochemical phenotypes implicated in ingestive control, and projecting to brown adipose tissue. In retrograde tracing experiments, a small percentage of arcuate nucleus POMC neurons was found to project to the dorsal vagal complex. Thus, melanocortin signaling in the brainstem is sufficient to alter food intake through changing the potency of satiety signals and to change sympathetic outflow. Although the anatomical findings support the involvement of hypothalamo-medullary POMC projections in mediating part of the descending, indirect signal, they do not rule out involvement of POMC neurons in the NTS in mediating part of the direct signal.
Introduction
Since the discovery of leptin, significant progress has been made in the identification of transmitters and peptides expressed by the hypothalamic neural circuitry that act as downstream mediators for leptin and other internal state factors involved in the control of food intake and energy homeostasis.
Proopiomelanocortin (POMC) and neuropeptide Y (NPY) neurons located in the arcuate nucleus have been recognized as some of the key mediators of leptin's central effects on food intake and energy balance (40) . Release of alpha-melanocyte-stimulating hormone (α-MSH) and agouti-related protein (AgRP) from terminals of POMC and NPY/AgRP neurons respectively, modulate food intake and energy balance very strongly through their actions on the melanocortin receptors MC3R and MC4R. Activation of the MC4R suppresses food intake and increases energy expenditure. AgRP acts as an endogenous antagonist for MC3/4R and potently stimulates food intake (37, 38) .
One population of leptin receptor-bearing arcuate nucleus neurons (15) co-expresses POMC (44, 49) and cocaine-and-amphetamine-related transcript (CART) (12, 21, 50, 72) , and projects heavily to most periventricular zone nuclei, including the paraventricular nucleus (PVN), to the lateral hypothalamic area (LH), and many other brain areas, including the dorsal vagal complex (DVC) and spinal cord (21, 22) . The POMC-derived peptide α-MSH (or its longer-lasting analog Melanotan-II [MT-II]) as well as CART-peptide potently suppress food intake when injected ICV (1, 42) .
Another population of leptin receptor-bearing neurons contains mRNA for NPY, often co-expresses AgRP (13) , and projects in parallel to most of the targets of POMC/CART neurons (5, 8, 19, 20, 22, 24) . NPY and AGRP have strong orexigenic effects when injected into the lateral or third cerebral ventricles, directly into the perifornical hypothalamus (37, 68) , or near the caudal brainstem (16, 78) .
As both arcuate nucleus POMC/CART and AgRP/NPY neurons have extensive projections throughout most of the brain, one of the open questions is which projections are particularly relevant for the modulation of food intake and energy balance. The brainstem harbors the neurons and circuits directly involved in ingestion, digestion, and absorption of food, as well as in utilization of metabolites and fuels (9) . The neural circuits controlling most of these tasks are complete within the brainstem and do not require the forebrain for their execution (35) . Based on experiments with the supracollicular decerebrate rat, it appears that the isolated brainstem is capable of terminating a meal and thus exhibiting the basic behavior of satiety (36) . However, the brainstem circuitry cannot translate signals related to longer-term energy status. Lack of appropriately increased meal size in response to food deprivation in the decerebrate rat suggests that the brainstem in isolation is not primarily involved in homeostatic control of energy balance and body weight. Furthermore, the brainstem circuitry cannot respond directly to cognitive, rewarding, emotional, and social influences and translate them into adaptive behavior. These signals [also referred to as indirect controls, see (66) ] originate from the hypothalamus and above.
Hypothalamic POMC and AgRP neurons might thus exert some of their effects on food intake and energy balance through their caudal brainstem projections. Evidence for this has been presented by the observations that melanocortin receptor ligands injected into the 4 th ventricle or directly into the dorsal vagal complex modulate food intake as efficiently as when injected into the 3 rd ventricle (34, 77, 78) .
However, because POMC is expressed in a small population of commissural NTS neurons, it is not clear whether under physiological conditions, α-MSH originating from this local population or from the hypothalamus is activating medullary MC4R to decrease food intake. Although it has been shown that both of the POMC neuron populations contribute to the α-MSH-immunoreactive fiber innervation of the caudal medulla, (57) , medulla-projecting POMC neurons have not been directly identified and quantified.
One of our aims was thus to identify hypothalamic POMC neurons with projections to the dorsal vagal complex using a retrograde tracing strategy. In addition, we wanted to analyze the anatomical relationship between α-MSH-immunoreactive fibers in the dorsal vagal complex and neurons expressing specific neurochemical markers, or expressing c-Fos in response to gastric nutrient infusion.
Pharmacological stimulation of MC3/4R receptors by means of 3 rd ventricular MTII injections has been
shown to decrease food intake by selectively decreasing meal size (4) . Although a site of action of MTII in the hypothalamus cannot be ruled out, this finding strongly implicates a direct role for medullary melanocortin receptors, because the caudal brainstem is thought to be most directly involved in the control of meal size (66) . Williams et al. then showed that 4 th ventricular MTII dose-dependently decreased consumption of glucose solution during a 30 min scheduled meal, suggesting amplification of post-ingestive feedback inhibition (77) . Thus, our second aim was to probe the effects of melanocortin receptor agonists and antagonists injected near the dorsal medulla on meal structure and food intake during a normal dark phase feeding period, using an automated feeding monitor.
Finally, ICV administration of MC4R-ligands has also been shown to modulate energy expenditure (76) . Thus, our third aim was to measure locomotor activity as well as indicators of sympathetic activity such as body temperature and heart rate. As an anatomical counterpart to this functional assessment, we also analyzed the relationship between α-MSH fibers and sympathetic premotor neurons innervating interscapular brown fat tissue.
Materials and Methods

Animals
Adult male Sprague Dawley rats (Harlan Industries, Indianapolis, IN) weighing 200 -320 g were housed in groups in shoebox cages or individually in hanging wire mesh cages in a climate controlled room (22+2 0 C) on a 12:12 h light cycle with lights on at 0600 h and lights off at 1800 h. Food and water were available ad libitum except as specified below. Eight-week-old GFP-labeled GABA male mice were obtained from the Jackson Laboratory [FVB-Tg (Gad GFP) 45704 Swn/J; Bar Harbor, ME] and were perfused upon arrival at the animal facility. All experimental protocols were approved by the Institutional Animal Care and Use Committee (Pennington Biomedical Research Center) and were conducted in compliance with USDA regulations and APS principles for research involving animals.
Chronic brain cannula implantation and microinjections
Animals were anesthetized with ketamine/acepromazine/xylazine (80/1.6/4.0 mg/kg, sc) and given atropine (1mg/kg, ip). Guide cannulas (24Ga for the 4 th ventricle and 22Ga for the NTS) were aimed 2.0 mm above the intended sites, and were cemented with four screws to the skull, and occluded with stainless steel obturators. Beveled stainless steel injectors (30Ga for the 4 th ventricle and 33Ga mounted onto a 26Ga sleeve for the NTS) extending 2.0 mm from the tip of the guide cannulas were used for injections. Coordinates were: 2.5 mm from the posterior occipital suture, 0.0 mm from the midline, and 6.0 mm below the skull, for 4 th ventricular infusions, and 0.0 mm from posterior occipital suture, 0.5 mm lateral, and 6.0 mm below the skull for direct NTS injections (with the tooth bar 4 mm below interaural zero). Seven to ten days were allowed for recovery, during which the animals were adapted to the injection procedure with 2-3 mock injections. Injections were carried out using a hand-held Hamilton microliter syringe attached to a piece of PE 20 tubing in volumes of 3µl for the 4 th ventricle and 0.3µl per side for the NTS. Cannula placement and patency was verified at the end of the experiment by checking the diffusion of Chicago Sky Blue (Sigma, St. Louis MO, 3µl, 2% in 0.5% Na acetate) for 5 min in the 4 th ventricle, or diffusion of Rhodamine labeled MTII (Phoenix Pharmaceuticals, Belmont CA, 0.3µl, 1.67 nmol in saline) for 30 min in the NTS.
Food intake
In Experiment 1, the effects on meal structure of the MC3/4R agonist MTII and the antagonist SHU9119 (Phoenix Pharmaceuticals) administered near the dorsal vagal complex via 4 th ventricular injections were tested. Rats bearing chronic guide cannulas aimed at the 4 th ventricle overlying the dorsal medulla were adapted to an automated feeding system with granulated diet available from a jar sitting on a balance that could be reached through a narrow alcove attached to a standard hanging wire cage.
Animals were adapted to a granulated high fat diet with 56% energy from fat (51) . This was done to increase caloric intake in the feeding monitor, because daily caloric intake of powdered chow was relatively low.
In a pilot study with 6 rats, MTII was injected at a dose of 0.1nmol in. This dose produced a 60% suppression of over-night food intake by decreasing meal size but also marginally decreasing meal frequency. We believe that this decrease in meal frequency was due to the large suppression of total intake, and we therefore used a lower dose (0.05 nmol) that should result in less suppression of total intake and no suppression of meal frequency for the main experiment.
In a first group of 12 rats, MTII (0.05 nmol in 3 µl sterile saline), or saline was injected over 2 minutes into the 4 th ventricle in counterbalanced order, at 1700 h. In a second group of 10 rats (4 rats that had MTII injections and 6 naïve rats), SHU9119 (0.1 nmol in 3 µl of saline), or saline was injected in the same way. This dose of SHU9119 was based on an earlier study that compared lateral ventricular with 4 th ventricular injection (34) . Rats were put back into the cage, and food intake was monitored for the entire dark period until 0900 h the next day. Injections were separated by 4 days to make sure the relatively long lasting effects of these MC4R ligands were not carrying over to the next test. The feeding records were analyzed using custom made software. A feeding bout was defined as a meal if ≥0.3 g of food was ingested and if it was separated by ≥10 minutes from another meal.
The purpose of Experiment 2 was to determine whether the SHU9119 administered directly into the dorsal vagal complex would increase food intake by mainly increasing meal size. In Experiment 1 we found that SHU9119 not only increased meal size, but also meal frequency, suggesting this might be a ceiling effect of meal size produced by the higher palatability of the high fat diet. Therefore, we used regular powdered chow (Purina 5001) in this experiment.
Six rats bearing chronic guide cannulas aimed at the dorsal vagal complex were adapted to an automated feeding system with powdered chow available from a jar sitting on a balance that could be reached through a narrow alcove attached to a standard hanging wire cage. After reaching a stable baseline intake, the MC3/4R antagonist SHU9119 (0.065 nmol in 300 nl sterile saline), or 300 nl saline was injected over 2 minutes unilaterally into the dorsal vagal complex at 1600 h, 2 h before dark onset.
This dose was similar to the one used by Williams et al. (78) . The injector was left in place for another minute and then removed and the cannula closed. The rat was returned to the feeding monitor and left undisturbed through the entire dark period (1800-0600 h), until 0800 on the next day. SHU9119 and control saline injections were given in a counterbalanced order 5 days apart.
Measurement of body temperature, heart rate, and locomotor activity
In ten rats, six with heart leads, core body temperature, physical activity, and heart rate were simultaneously registered telemetrically via a pre-implanted transponder with the VitalView Data Acquisition System (Mini-Mitter Company, Inc. OR). An E-Mitter transponder and a 4 th ventricular cannula was implanted in the same surgery. Briefly, after implantation of the 4 th ventricular cannula, a small 6 midline abdominal incision was made below the diaphragm. The transponder was slipped into the abdominal cavity along the sagital plane while the leads were tunneled under the skin and secured to the chest muscles with metal sutures. The abdominal opening was closed after verifying that the heart beat could be detected. The animals were allowed to recover for 7-10 days. On the test days, rats were briefly (< 2 h) deprived of food and water, injected with MTII (0.5 nmol in 3µl saline), SHU9119 (0.5 nmol), or saline alone into the 4 th ventricle, and placed back into their home cages. Pre-weighed normal rat chow was made available immediately. Heart rate, core temperature, and physical activity were continuously monitored for 20 hours at 1-minute intervals. Chow intake was also recorded after 2 h.
Retrograde tracing
To identify hypothalamic POMC neurons with projections to the dorsal vagal complex, the retrograde tracer cholera toxin B-subunit (CTB, List Biological Laboratories, Campbell, CA), or rhodamine-labeled fluorescent latex microspheres (retrobeads, Lumafluor Corp, Naples, FL), or Fluorogold (Fluorochrome, Inc., Denver, Co, 2% in sterile saline) was injected into the dorsal vagal complex. While all 3 tracers worked equally well, CTB produced the most robust labeling and was chosen for the quantitative analysis.
The dorsal surface of the medulla was exposed with the head fixed in a stereotaxic apparatus. A glass micropipette with a tip diameter of ~10µm was filled with 0.5% CTB in sterile saline, the retrobeads, or Fluorogold and pressure injections (100-200 nl total) were placed at 3 different rostrocaudal levels to blanket the entire dorsal vagal complex unilaterally. Animals were allowed 3 to 5 days for retrograde transport, at which time they were euthanized and the medulla (injection site) and the hypothalamus processed for CTB immunohistochemistry or directly visualized (retrobeads and Fluorogold).
Retrogradely labeled neurons in the rat medulla projecting to brown adipose tissue (BAT) were labeled using red fluorescent protein-expressing pseudorabies virus [PRV 614, a gift from Drs. Bruce Banfield and Roger Tsien (7) ]. The interscapular BAT pads were exposed and 3 sites per pad injected with 0.5µl of 8.4 x 10 8 plaque forming units/ml using a 5-µl Hamilton syringe fitted with a 26-gauge needle. After 4-5 days survival, the rats were perfused for histological processing.
Tissue processing and Immunohistochemistry
Rats or mice were deeply anesthetized with pentobarbital sodium (90 mg/kg, ip) and transcardially perfused with heparinized saline (20U/ml) followed by ice-cold 4% phosphate-buffered (pH 7.4) paraformaldehyde. Brains were extracted, blocked, and post-fixed in the same fixative overnight. Tissue was immersed for 24 h in 18% sucrose, 0.05% sodium azide in 0.1M phosphate buffered saline (PBS).
Twenty-to-thirty micron coronal sections of forebrain or medulla were cut in a cryostat and separated into five series. For immediate processing, sections were held in PBS (+4 o C), whereas for long-term storage (-20 o C), a cryoprotectant solution (50% PBS, 30% ethylene glycol, 20% glycerol) was used. Free-floating sections were pre-treated with 0.5% sodium borohydride in PBS to minimize aldehyde cross-linking of the fixative. Appropriate washing in PBS followed incubations. For immunoperoxidase methods, sections were treated with 1.5% hydrogen peroxide, 20% methanol, 0.25% Triton X-100 in PBS to quench endogenous peroxidases. Blocking in normal sera against the host of the secondary antibodies preceded the primary antibody incubations for both immunoperoxidase and fluorescent labeling. Primary antibodies were diluted in 0.1% gelatin, 0.05% sodium azide in PBS with 0.5% Triton X-100 (PBST), and incubated for 20hr at room temperature or for 48hr at +7 o C. Secondary antibodies were diluted in PBST and incubated at room temperature for 2hr. Biotinylated secondary antibodies (1:500, Jackson
ImmunoResearch, West Grove, PA), followed by incubation in avidin-biotin complex (1:500, Vectastain ABC Elite Kit, Vector Labs, Burlingame, CA), and visualization with appropriate chromagens were used for immunoperoxidase labeling, whereas simple fluorescent-conjugated secondaries were used in the fluorescent labeling. Negative controls (leaving out the primary antibody), or pre-adsorbed controls were used to establish the lack of non-specific staining.
For CTB, Fluorogold, and retrobead labeling, injection sites were verified in the medulla by directly mounting the sections on charged slides. Hypothalamus was processed free-floating. To visualize CTB, sections were incubated in goat antiserum to cholera toxin B-subunit (anti-choleragenoid, 1:20,000, List) followed by Cy-2-conjugated secondary antibody (1:200, Jackson). For double-labeling hypothalamic neurons, sections were incubated in rabbit anti-α-MSH (ImmunoStar Inc., Hudson, WI, 1:10,000) or rabbit anti-CART (Phoenix Pharmaceuticals, Belmont, CA, 1:10,000), followed by Cy-3-conjugated secondary antibody (1:600, Jackson) in combination with CTB or Fluorogold tracing, or Cy-2 in combination with retrobeads. Fluorescent-labeled sections were mounted in 100% glycerol with 5% n-propyl gallate as an antifade agent except for the retrobead-traced tissue, which was mounted in Fluoromount-G (Southern Biotechnology, Birmingham, AL).
For mapping α-MSH-ir axon profiles in the DVC, the primary antibody used was a sheep polyclonal diluted to 1:50,000 (Chemicon International, Temecula, CA).
Sections were labeled with an immunoperoxidase method using Vector SG (Vector Labs, Burlingame, CA) as the substrate. SG-labeled sections were mounted on clean slides, dried overnight, dehydrated and coverslipped with Entellon 
Activation of gastrointestinal signals to the NTS
To activate visceral satiety mechanisms known to result in increased c-Fos expression in brainstem neurons, rats were fitted with chronic gastric fistulas for the infusion of nutrients as described earlier (79) .
After recovery from surgery, rats were adapted to overnight food deprivation and the gastric infusion procedure in special cylindrical acrylic test cages. On test days, the gastric fistula was hooked up with an infusion line connected to a syringe pump containing a complete mixed liquid diet (vanilla flavored Ensure, 1 kcal/ml). One half-hour later the diet was infused at a rate of 1.6 ml/min for 10 minutes to mimic rate of ingestion, as determined in separate tests. At the end of infusion, the infusion catheter was capped without disturbing the animal, and ninety minutes after the start of infusion animals were euthanized with an overdose of Pentobarbital sodium and then transcardially perfused with 100 ml cold saline, followed by 500 ml phosphate-buffered (pH 7.4) paraformaldehyde. Brains were extracted and postfixed for an additional 2-4 hours.
Statistical analysis
Meal parameters were analyzed with separate one-way ANOVAs. Body temperature, heart rate, and locomotor activity were originally sampled every 60 sec. Floating averages were calculated for 15 minute intervals, and post hoc comparisons were made for specific time periods using repeated measures
ANOVAs. The number of POMC, CTB, and double-labeled neurons, as well as the percentages of double-labeled neurons that expressed POMC, or were retrogradely labeled, were analyzed with ANOVA (PROC MIXED in SAS 8.2), followed by Bonferroni-adjusted comparisons. Histological verification showed that the cannula tips were located in the NTS, and that the injected solution diffused throughout the dorsal vagal complex ( Fig. 3 ).
Results
Modulation of meal size by brainstem administration of melanocortin receptor ligands
Effects on body temperature, heart rate, and locomotor activity
Indices of autonomic functions and locomotor activity following 4 th ventricular administration of the MC4R ligands were measured telemetrically. Immediately following saline or drug injection there was an initial increase in all measures, due to the arousal associated with the injection. Injection of MTII (0.5 nmol) increased heart rate for about 8 hours after the injection, as compared to saline control ( Fig. 4) . A post hoc comparison for the time points 30 -300 minutes following injection revealed a significant effect (F[1,1,10] = 30.6, p < 0.001). MTII increased body temperature only slightly for the first 2 hours after injection. A post hoc comparison 60 -90 minutes following injection revealed a marginally significant difference (F[1,1,18] = 5.3, p = 0.034). There was also a tendency for MTII to increase locomotor activity during the first 3 hours following injection.
As could be expected, 4th ventricular administration of SHU9119 (0.5 nmol) produced opposite effects and, in contrast to the immediate effects of MTII, the effects of SHU9119 were delayed ( Fig. 5 ). Both body temperature and heart rate were lower for several hours starting about 6 hours following injection of SHU9119. A post hoc comparison 480 -530 minutes following injection revealed a marginally significant relative hypothermia (F[1,1,18] = 4.1, p = 0.058). The decrease in heart rate was not significant. The MC4R antagonist did not significantly affect locomotor activity at any time.
Retrograde tracing of medulla-projecting hypothalamic POMC neurons
The unilateral injections of CTB resulted in tracer diffusion to most of the NTS, dorsal motor nucleus, and area postrema caudal to the rostral end of the area postrema on the side of the injection, and limited diffusion to the medial portions of the NTS on the contralateral side ( Fig. 6A, B ). Adjacent structures such as the cuneate, gracilis, and hypoglossal nuclei and the reticular formation were infiltrated to various degrees in the 3 rats.
These injections resulted in dense retrograde labeling of neurons in the PVN and LH, and sparser labeling in the basomedial hypothalamus, as reported earlier (11) . Specifically, there were few retrogradely labeled neurons in the retrochiasmatic area and the more lateral aspects of the arcuate nucleus, the area of most POMC expression. The number of retrogradely labeled neurons was significantly smaller in the posterior half of the arcuate nucleus ( Fig. 7) .
Among the few retrogradely labeled neurons consistently found in each section, a small percentage exhibited α-MSH or CART-immunoreactivity ( Fig. 6C-E ). Quantitative analysis of labeled neurons within an area including the arcuate nucleus and its lateral extension that often also contains POMC positive neurons, showed that 6.4 + 1.7 % of all POMC neurons were retrogradely labeled with CTB, and that 9.7 + 2.5 % of the retrogradely labeled neurons in the area expressed α-MSH. There was considerable variation in these percentages among the 3 rats, and some of it could be explained by the differences in the size of tracer diffusion in the dorsal vagal complex. In rat # 1618, the injection site extended further laterally than in the 2 other animals (Fig. 6A) , and it had the highest percentage of POMC neurons retrogradely labeled (8.3%), and the highest percentage of retrogradely labeled neurons expressing POMC (13.7%). Further analysis showed that a higher number of double-labeled neurons and a higher percentage of POMC neurons with projections to the dorsal vagal complex were located in the anterior half as compared to the posterior half of the arcuate nucleus, while the percentage of retrogradely labeled neurons expressing POMC was similar ( Fig. 7) .
α-MSH-immunoreactive axons and terminals in the dorsal vagal complex
As reported earlier, α-MSH immunoreactive fibers quite selectively innervate the dorsal vagal complex, with few fibers in surrounding areas of the dorsal medulla ( Fig. 8) . Varicose α-MSH-ir fibers were found in all NTS subnuclei and the dorsal motor nucleus, but only the rare fiber was present in the area postrema.
The density of α-MSH-ir fibers was particularly high in the dorsal, commissural, and lateral NTS, including the interstitial and intermediate subnuclei around the solitary tract. In the dorsal motor nucleus, the highest density was found medially and in rostral sections.
Anatomical relationship between αMSH-ir axons and identified NTS neurons
Neurons expressing tyrosine hydroxylase were often in close anatomical contact to α-MSH-ir varicose axons ( Fig. 9) . Similarly, we found frequent contacts between varicose α-MSH-ir axon profiles and nitric oxide synthase-ir neurons as well as GFP-expressing GABA neurons in the mouse (Figs. 9C, D) . In contrast, GLP-1-ir neurons in the caudal NTS were rarely contacted by α-MSH-ir axon profiles (Fig. 9B) .
As previously reported, gastric infusion of a mixed meal stimulated the expression of c-Fos protein in neurons throughout the caudal NTS, particularly in the dorsomedial, medial, and commissural subnuclei ( Fig. 9E ). Mock gastric infusions resulted in very little Fos-expression in the dorsal vagal complex (not shown). On double-labeled sections, many close anatomical appositions between varicose α-MSH-ir fibers and Fos-ir cell nuclei were present throughout the area of co-distribution in the dorsal, commissural and medial subnuclei of NTS.
In an attempt to identify NTS neurons involved in sympathetic outflow we injected pseudorabies virus expressing red fluorescent protein into the interscapular brown adipose tissue pad of rats. This resulted in transsynaptic retrograde labeling of many neurons in the raphé nuclei and ventrolateral medulla, as well as a few neurons in the NTS, when the survival time was 4-5 days. Close appositions between α-MSH-ir varicose axon profiles and such BAT-projecting NTS neurons were present (Fig. 9D ).
Discussion
Control of meal size
The brain melanocortin system with its transmission at the MC4R melanocortin-receptor, has been demonstrated to mediate very potent effects on food intake and energy expenditure induced by leptin and other feedback signals (23, 38, 45) . Although the site of this action was originally thought to be in the hypothalamus, it was shown that injection of MC4R ligands into the caudal brainstem are sufficient to strongly modulate food intake (34, 77, 78) . Here we further show that the effects on spontaneous daily food intake by administration of MC4R ligands near the caudal brainstem or directly into the dorsal vagal complex are due to changes in meal size. MTII suppresses food intake by selectively decreasing meal size but not frequency, and thus increasing the satiating power of a given size meal. In contrast, SHU9119 increases food intake by selectively increasing meal size but not frequency, and thus decreasing the satiating power of a given size meal. We also show that this effect is not diet-specific, as it was manifest with both regular chow and high-fat diet. The results with direct dorsal vagal complex injections suggest this brain area as the site of action of the MC4R ligands. However, because we have not demonstrated that the same dose of SHU9119 used for direct parenchymal injections was without effect when injected into the 4 th ventricle (78), we cannot rule out action at another site via back-diffusion into the 4 th ventricle.
In light of earlier research, these findings are not surprising. Selective reduction of meal size has been demonstrated with MTII (4) or leptin (31) injected into the third ventricle, and leptin injected peripherally (18) . Furthermore, 4 th ventricular MTII dose-dependently reduced scheduled 30 minute glucose intake (77) . We are aware of only one demonstration of the opposite -ICV ghrelin injection increased mainly meal frequency but not meal size (30) What is the mechanism of this selective effect on meal size? Since the MC4R is highly expressed in the dorsal vagal complex (48, 52, 69) it seems most likely that 4 th ventricular and locally administered ligands directly bind to the MC4R on NTS and dmnX neurons. The effect of MC4R ligands on electrical activity of NTS neurons has not been studied. In preliminary experiments we found both excitatory and inhibitory effects of MTII on identified NTS neurons (unpublished observations). In cultured hypothalamic cell lines expressing MC4R, α-MSH dose-dependently stimulated cAMP production, and this effect was blocked by AGRP (47, 56) . We have recently demonstrated that 4 th ventricular injection of MTII and SHU9119 modulate spontaneous and CCK-induced phosphorylation of the extracellular signal-regulated kinases ERK1/2 (Sutton et al., submitted). Activation of this signaling cascade, including phosphorylation of the transcription factor CREB with MTII or α-MSH has also been shown in neurons of the paraventricular nucleus of the hypothalamus (17, 39, 64) . Together, these observations suggest that MC4R activation in NTS neurons stimulates specific intracellular signaling cascades leading to changes in cAMP, intracellular calcium, membrane potential, firing rate, and gene transcription. 
Stimulation of Fos expression in NTS neurons by stimuli associated with the ingestion of food has been
demonstrated in numerous studies (10, 27, 28, 32, 73, 79) . Any of these cellular changes could be at the beginning of the neural process of satiation. A meal is terminated when these changes in NTS neurons are propagated to oromotor control circuits in other parts of the caudal brainstem.
The concept of integration of direct and indirect controls was tested at both the behavioral and neural level. Leptin at doses that did not reduce liquid diet intake when administered to the 3 rd ventricle alone, significantly increased the suppression of intake induced by peripheral CCK administration or gastric nutrient infusion and, in parallel experiments, increased CCK and gastric nutrient infusion-induced Fos expression in the NTS (25, 26) . In another study, MTII did not augment feeding inhibition induced by intraduodenal glucose infusion (4), and it is thus possible that a more complete stimulation of sensors, including gastric distension signals might be necessary for the synergism to occur. Finally, these authors showed that central NPY injections had opposing effects on NTS neuronal firing activity induced by gastric distension (65) . However, in all these studies, the "indirect" signal represented by leptin, MTII or NPY was delivered to the 3 rd ventricle, making it impossible to pinpoint down the site(s) of action. Some of the effects may have been due to activation of medulla-projecting hypothalamic neurons and some to direct effects on NTS neurons.
Our demonstration that brainstem administration of MTII and SHU9119 reciprocally affects food intake through exclusive changes in meal size are consistent with these ideas of a brainstem/NTS integrator of direct and indirect controls of satiation and meal size. What we don't know is where the natural ligands for the MC4R come from, the brainstem or hypothalamus.
Control of energy expenditure
Activation of brainstem melanocortin receptors is known not only to suppress meal size and food intake but also to stimulate uncoupling protein 1 (UCP-1) in brown fat tissue (BAT) (76) . In support of this notion, we show here that 4 th ventricular MTII and SHU9119 increase and decrease, respectively, body temperature, and that α-MSH-ir axon profiles are in close anatomical contact with NTS neurons projecting to BAT. Using relatively long survival times, a considerable number of NTS neurons are retrogradely infected with pseudorabies virus injected into the interscapular BAT (6), suggesting a polysynaptic projection pathway that likely relays in the ventral medulla and spinal cord. The raphé pallidus nucleus in the ventromedial medulla has been shown to be a major site of sympathetic premotor neurons projecting to BAT (54). We have also been able to demonstrate α-MSH-ir fibers in close proximity to raphé pallidus neurons with BAT projections and in the A1/C1 area of the ventrolateral medulla (unpublished observations), suggesting multiple sites of endogenous melanocortin action on sympathetic outflow.
Thus, 4 th ventricular administration of MC4-receptor ligands could have affected BAT thermogenesis at any of these sites.
Innervation of the dorsal vagal complex by a-MSH containing fibers
The presence of α-MSH-ir and ACTH-ir fibers in the caudal medulla of rat and monkey has been reported before (43, 44, 46, 55, 57) , and our mapping study confirms the general pattern of innervation, with axon profiles distributed throughout the rostro-caudal extent of the NTS. To further characterize α-MSH innervation of the NTS, we labeled α-MSH axon profiles together with specific NTS neuronal phenotypes that have been implicated in the control of food intake. While our double-labeling study revealed close anatomical appositions between α-MSH-ir axon profiles and NA, GABA, and NOS expressing neurons, there was no preferential innervation of any of these neuron types. We observed many relatively thick and straight, but highly varicose, as well as thin and profusely (53) branching axon profiles, but not axon terminals wrapping around specific neurons. This might suggest that α-MSH action might not strictly depend on close synaptic transmission, but possibly on volume release, affecting any receptor in the vicinity of axons. It should also be kept in mind that confocal microscopy does not reveal functional synapses, and that additional approaches will be necessary for proof of synaptic relationships.
Catecholaminergic neurons in the NTS are known to respond to visceral satiety signals such as CCK and gastric distension (61, 62, 73, 79) , and their immunotoxic lesion abolishes CCK's suppression of food intake (59) . However, only a small fraction of neurons expressing c-Fos in response to visceral satiety signals are catecholaminergic. Our double-labeling study shows that many NTS neurons expressing c-Fos in response to gastric nutrient infusion are tightly surrounded by profusely branching α-MSH-ir fibers forming highly varicose terminals. These findings suggest that endogenously released α-MSH is in an excellent position to modulate both catecholaminergic and non-catecholaminergic NTS neurons involved in satiation.
GABA is an important inhibitory transmitter in the dorsal vagal complex, originating from both local neurons and distant projection neurons, some as far away as the forebrain (41) . GABAA-receptors are located on central terminals of vagal afferents and on dendrites and somata of NTS neurons and vagal motor neurons (3) . As summarized by Travagli and Rogers, electrophysiological studies have clearly demonstrated a role for GABA and GABAA-receptors in the elaboration of vago-vagal reflexes (70) , and functional studies have shown involvement in esophageal and gastrointestinal motor reflexes, (74, 80) important for ingestive control.
Although we had difficulty demonstrating close anatomical contacts between α-MSH fibers and GLP-1ir neurons, we cannot rule out such an interaction. GLP-1 neurons located in the mainly caudal NTS are thought to play a role in satiation, particularly satiation that is accompanied by signs of nausea and typically involves the oxytocin system, such as occurs after the ingestion of unusually large meals (60, 63, 71 ). Thus, it is possible that the food intake-suppressing effects of α-MSH are partially mediated through brainstem GLP-1 neurons.
Origin of MC4-receptor ligands
There are two populations of POMC neurons in the brain, one in the arcuate nucleus/retrochiasmatic area of the medial hypothalamus (44) , and one in the nucleus of the solitary tract (29, 43, 57, 75) . The brainstem population can be demonstrated with immunohistochemistry only by using massive doses of intraventricular colchicine (14, 43, 57, 75) , and with a riboprobe for in situ hybridization only after prolonged exposure (14) , suggesting that the normal expression level is much lower than in the hypothalamus. Furthermore, RT-PCR analysis revealed presence of the predicted 742-bp product in the rat and human medulla, but also in other parts of the rat brain (33) . Thus, the POMC gene is expressed in several areas of the rat brain, but the contribution of the low level expression sites to the control of energy balance is not clear. Most recently transgenic mice with EGFP-expression under the POMC promoter were used to vitally stain brainstem POMC neurons, and to show that ip cholecystokinin injection induced c-Fos in 30% of NTS POMC-EGFP neurons (29) . Thus one potential source of α-MSH, the natural ligand for the MC4R, is the local POMC neurons in the NTS.
However, it is also likely that α-MSH is released from NTS-projecting hypothalamic POMC neurons. POMC neurons with projections to the dorsal vagal complex. However, if these few neurons branch profusely in the dorsal vagal complex they could still exert significant modulatory effects. It is also interesting to note that among the retrogradely labeled neurons, only about 10% express α-MSH, with the remaining 90% expressing a neurochemical phenotype that remains to be determined.
Early studies using surgical lesions and transections at various levels between the hypothalamus and
Conclusions
The behavioral demonstration that melanocortin ligands administered near or within the caudal brainstem modulate food intake by selectively changing meal size strongly suggests that melanocortin signaling in the brainstem is necessary to alter food intake. The close appositions between α-MSH-ir axons and NTS neurons activated by gastric nutrient infusion provide a general anatomical basis for such modulation, but do not distinguish between pre-and postsynaptic mechanisms. The presence of POMC neurons in the arcuate nucleus of the hypothalamus with projections to the dorsal vagal complex suggest that they provide the melanocortin receptor ligand α-MSH, but a role for the POMC neuron population in the NTS cannot be excluded. with either SHU9119 (0.5 nmol) or saline into the 4 th ventricle, and parameters were monitored for 20 h. 
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